The Missing lnc(RNA) between the pancreatic β-cell and diabetes

Frontiers in Genetics

Volumn 5, Issue JUL, 2014, Pages

  Kameswaran, Vasumathi ^a   Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Diabetes mellitus; Imprinting control region (ICR); lncRNA; MEG3; cell biology

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NOTCH RECEPTOR; POTASSIUM CHANNEL KCNQ1; RNA H19; SOMATOMEDIN B RECEPTOR; TRANSCRIPTOME; UNTRANSLATED RNA; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DESTRUCTION; DIABETES MELLITUS; DNA METHYLATION; GENE LOCUS; GENETIC ASSOCIATION; GENOME IMPRINTING; GLUCOSE HOMEOSTASIS; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HUMAN; LOSS OF FUNCTION MUTATION; METABOLIC DISORDER; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOGENESIS; PROTEIN EXPRESSION;

EID: 84906248499     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00200     Document Type: Article

References (142)

1. Abdallah, B. M., Beck-Nielsen, H., and Gaster, M. (2013). FA1 induces pro-inflammatory and anti-adipogenic pathways/markers in human myotubes established from lean, obese, and type 2 diabetic subjects but not insulin resistance. Front. Endocrinol. (Lausanne) 4:45. doi: 10.3389/fendo.2013.00045
2. Abramowicz, M. J., Andrien, M., Dupont, E., Dorchy, H., Parma, J., Duprez, L., et al. (1994). Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis of pancreatic beta cells causing diabetes mellitus. J. Clin. Invest. 94, 418-421. doi: 10.1172/JCI117339
3. Appelbe, O. K., Yevtodiyenko, A., Muniz-Talavera, H., and Schmidt, J. V. (2013). Conditional deletions refine the embryonic requirement for Dlk1. Mech. Dev. 130, 143-159. doi: 10.1016/j.mod.2012.09.010
4. Arima, T., Drewell, R. A., Oshimura, M., Wake, N., and Surani, M. A. (2000). A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC. Genomics 67, 248-255. doi: 10.1006/geno.2000.6266
5. Arima, T., Kamikihara, T., Hayashida, T., Kato, K., Inoue, T., Shirayoshi, Y., et al. (2005). ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome. Nucleic Acids Res. 33, 2650-2660. doi: 10.1093/nar/gki555
6. Association, A. D. (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36, 1033-1046. doi: 10.2337/dc12-2625
7. Avrahami, D., Li, C., Yu, M., Jiao, Y., Zhang, J., Naji, A., et al. (2014). Targeting the cell cycle inhibitor p57Kip2 promotes adult human Β cell replication. J. Clin. Invest. 124, 670-674. doi: 10.1172/JCI69519
8. Barlow, D. P. (2011). Genomic imprinting: a mammalian epigenetic discovery model. Annu. Rev. Genet. 45, 379-403. doi: 10.1146/annurev-genet-110410-132459
9. Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., et al. (2009). Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703-707. doi: 10.1038/ng.381
10. Bartolomei, M. S., and Ferguson-Smith, A. C. (2011). Mammalian genomic imprinting. Cold Spring Harb. Perspect. Biol. 3:a002592. doi: 10.1101/cshperspect.a002592
11. Bartolomei, M. S., Zemel, S., and Tilghman, S. M. (1991). Parental imprinting of the mouse H19 gene. Nature 351, 153-155. doi: 10.1038/351153a0
12. Batista, P. J., and Chang, H. Y. (2013). Long noncoding RNAs: cellular address codes in development and disease. Cell 152, 1298-1307. doi: 10.1016/j.cell.2013.02.012
13. Bell, A. C., and Felsenfeld, G. (2000). Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482-485. doi: 10.1038/35013100
14. Benetatos, L., Dasoula, A., Hatzimichael, E., Georgiou, I., Syrrou, M., and Bourantas, K. L. (2008). Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin. Lymphoma Myeloma 8, 171-175. doi: 10.3816/CLM.2008.n.021
15. Benetatos, L., Vartholomatos, G., and Hatzimichael, E. (2011). MEG3 imprinted gene contribution in tumorigenesis. Int. J. Cancer 129, 773-779. doi: 10.1002/ijc.26052
16. Bernstein, E., and Allis, C. D. (2005). RNA meets chromatin. Genes Dev. 19, 1635-1655. doi: 10.1101/gad.1324305
17. Bramswig, N. C., Everett, L. J., Schug, J., Dorrell, C., Liu, C., Luo, Y., et al. (2013). Epigenomic plasticity enables human pancreatic a to Β cell reprogramming. J. Clin. Invest. 123, 1275-1284. doi: 10.1172/JCI66514
18. Bramswig, N. C., and Kaestner, K. H. (2012). Epigenetics and diabetes treatment: an unrealized promise? Trends Endocrinol. Metab. 23, 286-291. doi: 10.1016/j.tem.2012.02.002
19. Brannan, C. I., Dees, E. C., Ingram, R. S., and Tilghman, S. M. (1990). The product of the H19 gene may function as an RNA. Mol. Cell. Biol. 10, 28-36.
20. Brown, C. J., Ballabio, A., Rupert, J. L., Lafreniere, R. G., Grompe, M., Tonlorenzi, R., et al. (1991). A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349, 38-44. doi: 10.1038/349038a0
21. Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., et al. (2011). Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915-1927. doi: 10.1101/gad.17446611
22. Carlsson, C., Tornehave, D., Lindberg, K., Galante, P., Billestrup, N., Michelsen, B., et al. (1997). Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/delta-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology 138, 3940-3948. doi: 10.1210/endo.138.9.5408
23. Carninci, P., Kasukawa, T., Katayama, S., Gough, J., Frith, M. C., Maeda, N., et al. (2005). The transcriptional landscape of the mammalian genome. Science 309, 1559-1563. doi: 10.1126/science.1112014
24. Cech, T. R., and Steitz, J. A. (2014). The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157, 77-94. doi: 10.1016/j.cell.2014.03.008
25. Cho, Y. S., Chen, C.-H., Hu, C., Long, J., Ong, R. T. H., Sim, X., et al. (2012). Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat. Genet. 44, 67-72. doi: 10.1038/ng.1019
26. Ciani, E., Hoffmann, A., Schmidt, P., Journot, L., and Spengler, D. (1999). Induction of the PAC1-R (PACAP-type I receptor) gene by p53 and Zac. Brain Res. Mol. Brain Res. 69, 290-294. doi: 10.1016/S0169-328X(99)00116-3
27. Cui, H., Hedborg, F., He, L., Nordenskjöld, A., Sandstedt, B., Pfeifer-Ohlsson, S., et al. (1997). Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cancer Res. 57, 4469-4473.
28. da Rocha, S. T., Edwards, C. A., Ito, M., Ogata, T., and Ferguson-Smith, A. C. (2008). Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet. 24, 306-316. doi: 10.1016/j.tig.2008.03.011
29. Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., et al. (2014). Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 10:e1004160. doi: 10.1371/journal.pgen.1004160
30. DeChiara, T. M., Efstratiadis, A., and Robertson, E. J. (1990). A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78-80. doi: 10.1038/345078a0
31. de Lonlay, P., Fournet, J. C., Rahier, J., Gross-Morand, M. S., Poggi-Travert, F., Foussier, V., et al. (1997). Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J. Clin. Invest. 100, 802-807. doi: 10.1172/JCI119594
32. Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., et al. (2012). The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775-1789. doi: 10.1101/gr.132159.111
33. Devedjian, J. C., George, M., Casellas, A., Pujol, A., Visa, J., Pelegrín, M., et al. (2000). Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J. Clin. Invest. 105, 731-740. doi: 10.1172/JCI5656
34. Ding, G.-L., Wang, F.-F., Shu, J., Tian, S., Jiang, Y., Zhang, D., et al. (2012). Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes 61, 1133-1142. doi: 10.2337/db11-1314
35. Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., et al. (2012). Landscape of transcription in human cells. Nature 489, 101-108. doi: 10.1038/nature11233
36. Dorrell, C., Schug, J., Lin, C. F., Canaday, P. S., Fox, A. J., Smirnova, O., et al. (2011). Transcriptomes of the major human pancreatic cell types. Diabetologia 54, 2832-2844. doi: 10.1007/s00125-011-2283-5
37. Dupuis, J., Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., Jackson, A. U., et al. (2010). New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116. doi: 10.1038/ng.520
38. Du, X., Rousseau, M., Ounissi-Benkalha, H., Marchand, L., Jetha, A., Paraskevas, S., et al. (2011). Differential expression pattern of ZAC in developing mouse and human pancreas. J. Mol. Histol. 42, 129-136. doi: 10.1007/s10735-011-9315-9
39. Eißmann, M., Gutschner, T., Hämmerle, M., Günther, S., Caudron-Herger, M., Groβ, M., et al. (2012). Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 9, 1076-1087. doi: 10.4161/rna.21089
40. Engel, N., West, A. G., Felsenfeld, G., and Bartolomei, M. S. (2004). Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations. Nat. Genet. 36, 883-888. doi: 10.1038/ng1399
41. Fajans, S. S., Bell, G. I., and Polonsky, K. S. (2001). Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345, 971-980. doi: 10.1056/NEJMra002168
42. Falix, F. A., Aronson, D. C., Lamers, W. H., and Gaemers, I. C. (2012). Possible roles of DLK1 in the Notch pathway during development and disease. Biochim. Biophys. Acta 1822, 988-995. doi: 10.1016/j.bbadis.2012.02.003
43. Fatica, A., and Bozzoni, I. (2014). Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7-21. doi: 10.1038/nrg3606
44. Fitzpatrick, G. V., Soloway, P. D., and Higgins, M. J. (2002). Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nat. Genet. 32, 426-431. doi: 10.1038/ng988
45. Fournet, J. C., Mayaud, C., de Lonlay, P., Gross-Morand, M. S., Verkarre, V., Castanet, M., et al. (2001). Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Am. J. Pathol. 158, 2177-2184. doi: 10.1016/S0002-9440(10)64689-5
46. Friedrichsen, B. N., Carlsson, C., Møldrup, A., Michelsen, B., Jensen, C. H., Teisner, B., et al. (2003). Expression, biosynthesis and release of preadipocyte factor-1/delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications. J. Endocrinol. 176, 257-266. doi: 10.1677/joe.0.1760257
47. Gardner, R. J., Mackay, D. J., Mungall, A. J., Polychronakos, C., Siebert, R., Shield, J. P., et al. (2000). An imprinted locus associated with transient neonatal diabetes mellitus. Hum. Mol. Genet. 9, 589-596. doi: 10.1093/hmg/9.4.589
48. Gaulton, K. J., Nammo, T., Pasquali, L., Simon, J. M., Giresi, P. G., Fogarty, M. P., et al. (2010). A map of open chromatin in human pancreatic islets. Nat. Genet. 42, 255-259. doi: 10.1038/ng.530
49. Gicquel, C., Rossignol, S., Cabrol, S., Houang, M., Steunou, V., Barbu, V., et al. (2005). Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat. Genet. 37, 1003-1007. doi: 10.1038/ng1629
50. Grote, P., Wittler, L., Hendrix, D., Koch, F., Währisch, S., Beisaw, A., et al. (2013). The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev. Cell 24, 206-214. doi: 10.1016/j.devcel.2012.12.012
51. Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., et al. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076. doi: 10.1038/nature08975
52. Gutschner, T., Hämmerle, M., and Diederichs, S. (2013). MALAT1 - a paradigm for long noncoding RNA function in cancer. J. Mol. Med. 91, 791-801. doi: 10.1007/s00109-013-1028-y
53. Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., et al. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227. doi: 10.1038/nature07672
54. Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., et al. (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300. doi: 10.1038/nature10398
55. Guttman, M., and Rinn, J. L. (2012). Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346. doi: 10.1038/nature10887
56. Hales, C. N. (2001). The thrifty phenotype hypothesis. Br. Med. Bull. 60, 5-20. doi: 10.1093/bmb/60.1.5
57. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., and Tycko, B. (1993). Tumour-suppressor activity of H19 RNA. Nature 365, 764-767. doi: 10.1038/365764a0
58. Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., et al. (2008). Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. U.S.A. 105, 17046-17049. doi: 10.1073/pnas.0806560105
59. Helwak, A., Kudla, G., Dudnakova, T., and Tollervey, D. (2013). Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654-665. doi: 10.1016/j.cell.2013.03.043
60. Hussain, K., Cosgrove, K. E., Shepherd, R. M., Luharia, A., Smith, V. V., Kassem, S., et al. (2005). Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann syndrome due to defects in the function of pancreatic beta-cell adenosine triphosphate-sensitive potassium channels. J. Clin. Endocrinol. Metab. 90, 4376-4382. doi: 10.1210/jc.2005-0158
61. Hutchinson, J. N., Ensminger, A. W., Clemson, C. M., Lynch, C. R., Lawrence, J. B., and Chess, A. (2007). A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8:39. doi: 10.1186/1471-2164-8-39
62. Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., and Tuomilehto, J. (2003). Genetic liability of type 1 diabetes and the onset age among 22, 650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52, 1052-1055. doi: 10.2337/diabetes.52.4.1052
63. Ideraabdullah, F. Y., Vigneau, S., and Bartolomei, M. S. (2008). Genomic imprinting mechanisms in mammals. Mutat. Res. 647, 77-85. doi: 10.1016/j.mrfmmm.2008.08.008
64. Ji, P., Diederichs, S., Wang, W., Böing, S., Metzger, R., Schneider, P. M., et al. (2003). MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. doi: 10.1038/sj.onc.1206928
65. Kagami, M., O'Sullivan, M. J., Green, A. J., Watabe, Y., Arisaka, O., Masawa, N., et al. (2010). The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS Genet. 6:e1000992. doi: 10.1371/journal.pgen.1000992.s006
66. Kagami, M., Sekita, Y., Nishimura, G., Irie, M., Kato, F., Okada, M., et al. (2008). Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat. Genet. 40, 237-242. doi: 10.1038/ng.2007.56
67. Kameswaran, V., Bramswig, N. C., McKenna, L. B., Penn, M., Schug, J., Hand, N. J., et al. (2014). Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 19, 135-145. doi: 10.1016/j.cmet.2013.11.016
68. Kamiya, M., Judson, H., Okazaki, Y., Kusakabe, M., Muramatsu, M., Takada, S., et al. (2000). The cell cycle control gene ZAC/PLAGL1 is imprinted - a strong candidate gene for transient neonatal diabetes. Hum. Mol. Genet. 9, 453-460. doi: 10.1093/hmg/9.3.453
69. Kaneko, S., Bonasio, R., Saldaña-Meyer, R., Yoshida, T., Son, J., Nishino, K., et al. (2014). Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Mol. Cell 53, 290-300. doi: 10.1016/j.molcel.2013.11.012
70. Kang, H. S., Kim, Y.-S., ZeRuth, G., Beak, J. Y., Gerrish, K., Kilic, G., et al. (2009). Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol. Cell. Biol. 29, 6366-6379. doi: 10.1128/MCB.01259-09
71. Kawakami, T., Chano, T., Minami, K., Okabe, H., Okada, Y., and Okamoto, K. (2006). Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum. Mol. Genet. 15, 821-830. doi: 10.1093/hmg/ddl001
72. Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., et al. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U.S.A. 106, 11667-11672. doi: 10.1073/pnas.0904715106
73. Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher, S., et al. (2009). Parental origin of sequence variants associated with complex diseases. Nature 462, 868-874. doi: 10.1038/nature08625
74. Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., et al. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452. doi: 10.1038/nbt1393
75. Ku, G. M., Kim, H., Vaughn, I. W., Hangauer, M. J., Myung Oh, C., German, M. S., et al. (2012). Research resource: RNA-Seq reveals unique features of the pancreatic Β-cell transcriptome. Mol. Endocrinol. 26, 1783-1792. doi: 10.1210/me.2012-1176
76. Latos, P. A., Pauler, F. M., Koerner, M. V., Senergin, H. B., Hudson, Q. J., Stocsits, R. R., et al. (2012). Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science 338, 1469-1472. doi: 10.1126/science.1228110
77. Lee, J. T., and Bartolomei, M. S. (2013). X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 152, 1308-1323. doi: 10.1016/j.cell.2013.02.016
78. Lee, M. P., DeBaun, M. R., Mitsuya, K., Galonek, H. L., Brandenburg, S., Oshimura, M., et al. (1999). Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl. Acad. Sci. U.S.A. 96, 5203-5208. doi: 10.1073/pnas.96.9.5203
79. Lee, M. P., Hu, R. J., Johnson, L. A., and Feinberg, A. P. (1997). Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet. 15, 181-185. doi: 10.1038/ng0297-181
80. Maass, P. G., Luft, F. C., and Bähring, S. (2014). Long non-coding RNA in health and disease. J. Mol. Med. 92, 337-346. doi: 10.1007/s00109-014-1131-8
81. Macias, S., Plass, M., Stajuda, A., Michlewski, G., Eyras, E., and Cáceres, J. F. (2012). DGCR8 HITS-CLIP reveals novel functions for the Microprocessor. Nat. Struct. Mol. Biol. 19, 760-766. doi: 10.1038/nsmb.2344
82. Mackay, D. J. G., Coupe, A.-M., Shield, J. P. H., Storr, J. N. P., Temple, I. K., and Robinson, D. O. (2002). Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus. Hum. Genet. 110, 139-144. doi: 10.1007/s00439-001-0671-5
83. Mao, Y. S., Zhang, B., and Spector, D. L. (2011). Biogenesis and function of nuclear bodies. Trends Genet. 27, 295-306. doi: 10.1016/j.tig.2011.05.006
84. Martens, J. A., Laprade, L., and Winston, F. (2004). Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 429, 571-574. doi: 10.1038/nature02538
85. Mattick, J. S., and Makunin, I. V. (2006). Non-coding RNA. Hum. Mol. Genet. 15, R17-R29. doi: 10.1093/hmg/ddl046
86. McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363, 2339-2350. doi: 10.1056/NEJMra0906948
87. Medici, F., Hawa, M., Ianari, A., Pyke, D. A., and Leslie, R. D. (1999). Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42, 146-150. doi: 10.1007/s001250051132
88. Mendell, J. T., and Olson, E. N. (2012). MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187. doi: 10.1016/j.cell.2012.02.005
89. Mercer, T. R., Dinger, M. E., Sunkin, S. M., Mehler, M. F., and Mattick, J. S. (2008). Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 105, 716-721. doi: 10.1073/pnas.0706729105
90. - adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women. Stem Cell Res 9, 35-48. doi: 10.1016/j.scr.2012.04.001
91. Monk, D., Arnaud, P., Apostolidou, S., Hills, F. A., Kelsey, G., Stanier, P., et al. (2006). Limited evolutionary conservation of imprinting in the human placenta. Proc. Natl. Acad. Sci. U.S.A. 103, 6623-6628. doi: 10.1073/pnas.0511031103
92. Morán, I., Akerman, I., van de Bunt, M., Xie, R., Benazra, M., Nammo, T., et al. (2012). Human Β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 16, 435-448. doi: 10.1016/j.cmet.2012.08.010
93. Nakagawa, S., Ip, J. Y., Shioi, G., Tripathi, V., Zong, X., Hirose, T., et al. (2012). Malat1 is not an essential component of nuclear speckles in mice. RNA 18, 1487-1499. doi: 10.1261/rna.033217.112
94. Nesterova, T. B., Slobodyanyuk, S. Y., Elisaphenko, E. A., Shevchenko, A. I., Johnston, C., Pavlova, M. E., et al. (2001). Characterization of the genomic Xist locus in rodents reveals conservation of overall gene structure and tandem repeats but rapid evolution of unique sequence. Genome Res. 11, 833-849. doi: 10.1101/gr.174901
95. Nogueira, T. C., Paula, F. M., Villate, O., Colli, M. L., Moura, R. F., Cunha, D. A., et al. (2013). GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 9:e1003532. doi: 10.1371/journal.pgen.1003532
96. Ohlsson, R., Nyström, A., Pfeifer-Ohlsson, S., Töhönen, V., Hedborg, F., Schofield, P., et al. (1993). IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat. Genet. 4, 94-97. doi: 10.1038/ng0593-94
97. O'Rahilly, S. (2009). Human genetics illuminates the paths to metabolic disease. Nature 462, 307-314. doi: 10.1038/nature08532
98. Parker-Katiraee, L., Carson, A. R., Yamada, T., Arnaud, P., Feil, R., Abu-Amero, S. N., et al. (2007). Identification of the imprinted KLF14 transcription factor undergoing human-specific accelerated evolution. PLoS Genet. 3:e65. doi: 10.1371/journal.pgen.0030065
99. Park, J. H., Stoffers, D. A., Nicholls, R. D., and Simmons, R. A. (2008). Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118, 2316-2324. doi: 10.1172/JCI33655
100. Pasquali, L., Gaulton, K. J., Rodríguez-Seguí, S. A., Mularoni, L., Miguel-Escalada, I., Akerman, I., et al. (2014). Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 46, 136-143. doi: 10.1038/ng.2870
101. Ponjavic, J., Ponting, C. P., and Lunter, G. (2007). Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 17, 556-565. doi: 10.1101/gr.6036807
102. Ravassard, P., Hazhouz, Y., Pechberty, S., Bricout-Neveu, E., Armanet, M., Czernichow, P., et al. (2011). A genetically engineered human pancreatic Β cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 121, 3589-3597. doi: 10.1172/JCI58447
103. Ravelli, A. C., van der Meulen, J. H., Michels, R. P., Osmond, C., Barker, D. J., Hales, C. N., et al. (1998). Glucose tolerance in adults after prenatal exposure to famine. Lancet 351, 173-177. doi: 10.1016/S0140-6736(97)07244-9
104. Rinn, J. L., and Chang, H. Y. (2012). Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166. doi: 10.1146/annurev-biochem-051410-092902
105. Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., et al. (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323. doi: 10.1016/j.cell.2007.05.022
106. Roseboom, T., de Rooij, S., and Painter, R. (2006). The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 82, 485-491. doi: 10.1016/j.earlhumdev.2006.07.001
107. Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., et al. (2012). Reduced insulin exocytosis in human pancreatic Β-cells with gene variants linked to type 2 diabetes. Diabetes 61, 1726-1733. doi: 10.2337/db11-1516
108. Schmidt, J. V., Matteson, P. G., Jones, B. K., Guan, X. J., and Tilghman, S. M. (2000). The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev. 14, 1997-2002. doi: 10.1101/gad.14.16.1997
109. Segrè, A. V., DIAGRAM Consortium, MAGIC investigators, Groop, L., Mootha, V. K., Daly, M. J., et al. (2010). Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 6:e1001058. doi: 10.1371/journal.pgen.1001058
110. Seitz, H., Royo, H., Bortolin, M.-L., Lin, S.-P., Ferguson-Smith, A. C., and Cavaille, J. (2004). A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 14, 1741-1748. doi: 10.1101/gr.2743304
111. Sekita, Y., Wagatsuma, H., Nakamura, K., Ono, R., Kagami, M., Wakisaka, N., et al. (2008). Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat. Genet. 40, 243-248. doi: 10.1038/ng.2007.51
112. Shield, J. P., Gardner, R. J., Wadsworth, E. J., Whiteford, M. L., James, R. S., Robinson, D. O., et al. (1997). Aetiopathology and genetic basis of neonatal diabetes. Arch. Dis. Child. Fetal Neonatal Ed. 76, F39-F42. doi: 10.1136/fn.76.1.F39
113. Small, K. S., Hedman, A. K., Grundberg, E., Nica, A. C., Thorleifsson, G., Kong, A., et al. (2011). Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 43, 561-564. doi: 10.1038/ng.833
114. Smas, C. M., and Sul, H. S. (1993). Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73, 725-734. doi: 10.1016/0092-8674(93)90252-L
115. Spengler, D., Villalba, M., Hoffmann, A., Pantaloni, C., Houssami, S., Bockaert, J., et al. (1997). Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 16, 2814-2825. doi: 10.1093/emboj/16.10.2814
116. Stadnick, M. P., Pieracci, F. M., Cranston, M. J., Taksel, E., Thorvaldsen, J. L., and Bartolomei, M. S. (1999). Role of a 461-bp G-rich repetitive element in H19 transgene imprinting. Dev. Genes Evol. 209, 239-248. doi: 10.1007/s004270050248
117. Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., et al. (2010). Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175-181. doi: 10.1038/nature09017
118. Taft, R. J., Pheasant, M., and Mattick, J. S. (2007). The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 29, 288-299. doi: 10.1002/bies.20544
119. Temple, I. K., Gardner, R. J., Mackay, D. J., Barber, J. C., Robinson, D. O., and Shield, J. P. (2000). Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 49, 1359-1366. doi: 10.2337/diabetes.49.8.1359
120. Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713. doi: 10.1038/nature09270
121. Thorvaldsen, J. L., and Bartolomei, M. S. (2007). SnapShot: imprinted gene clusters. Cell 130:958. doi: 10.1016/j.cell.2007.08.033
122. Tierling, S., Dalbert, S., Schoppenhorst, S., Tsai, C.-E., Oliger, S., Ferguson-Smith, A. C., et al. (2006). High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. Genomics 87, 225-235. doi: 10.1016/j.ygeno.2005.09.018
123. Tornehave, D., Jensen, C. H., Teisner, B., and Larsson, L. I. (1996). FA1 immunoreactivity in endocrine tumours and during development of the human fetal pancreas; negative correlation with glucagon expression. Histochem. Cell Biol. 106, 535-542. doi: 10.1007/BF02473268
124. Travers, M. E., Mackay, D. J. G., Dekker Nitert, M., Morris, A. P., Lindgren, C. M., Berry, A., et al. (2013). Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 62, 987-992. doi: 10.2337/db12-0819/-/DC1
125. Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., et al. (2010). The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925-938. doi: 10.1016/j.molcel.2010.08.011
126. Ulitsky, I., Shkumatava, A., Jan, C. H., Sive, H., and Bartel, D. P. (2011). Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 147, 1537-1550. doi: 10.1016/j.cell.2011.11.055
127. Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G., et al. (2008). SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40, 1098-1102. doi: 10.1038/ng.208
128. Valleley, E. M., Cordery, S. F., and Bonthron, D. T. (2007). Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters. Hum. Mol. Genet. 16, 972-981. doi: 10.1093/hmg/ddm041
129. Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., et al. (2010). Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579-589. doi: 10.1038/ng.609
130. Wallace, C., Smyth, D. J., Maisuria-Armer, M., Walker, N. M., Todd, J. A., and Clayton, D. G. (2010). The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 42, 68-71. doi: 10.1038/ng.493
131. Weinmann, L., Höck, J., Ivacevic, T., Ohrt, T., Mütze, J., Schwille, P., et al. (2009). Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136, 496-507. doi: 10.1016/j.cell.2008.12.023
132. Yada, T., Sakurada, M., Ihida, K., Nakata, M., Murata, F., Arimura, A., et al. (1994). Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J. Biol. Chem. 269, 1290-1293.
133. Yang, L., Lin, C., Liu, W., Zhang, J., Ohgi, K. A., Grinstein, J. D., et al. (2011). ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147, 773-788. doi: 10.1016/j.cell.2011.08.054
134. Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., et al. (2008). Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40, 1092-1097. doi: 10.1038/ng.207
135. ZeRuth, G. T., Takeda, Y., and Jetten, A. M. (2013). The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription. Mol. Endocrinol. 27, 1692-1705. doi: 10.1210/me.2013-1117
136. Zhang, B., Arun, G., Mao, Y. S., Lazar, Z., and Hung, G. (2012). The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2, 111-123. doi: 10.1016/j.celrep.2012.06.003
137. Zhang, H., Zeitz, M. J., Wang, H., Niu, B., Ge, S., Li, W., et al. (2014). Long noncoding RNA-mediated intrachromosomal interactions promote imprinting at the Kcnq1 locus. J. Cell Biol. 204, 61-75. doi: 10.1083/jcb.201304152
138. Zhao, J., Dahle, D., Zhou, Y., Zhang, X., and Klibanski, A. (2005). Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J. Clin. Endocrinol. Metab. 90, 2179-2186. doi: 10.1210/jc.2004-1848
139. Zhao, J., Ohsumi, T. K., Kung, J. T., Ogawa, Y., Grau, D. J., Sarma, K., et al. (2010). Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939-953. doi: 10.1016/j.molcel.2010.12.011
140. Zhou, Y., Zhang, X., and Klibanski, A. (2012). MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol. 48, R45-R53. doi: 10.1530/JME-12-0008
141. Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., et al. (2007). Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem. 282, 24731-24742. doi: 10.1074/jbc.M702029200
142. Zimmet, P., Alberti, K. G., and Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature 414, 782-787. doi: 10.1038/414782a